BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23089069)

  • 1. [Are there any dosimetric advantages in using VMAT for treatment of locally advanced non-small cell lung cancer?].
    Rousseau D; Autret D; Krhili S; Yossi S; Dupas A; Edouard M; Mahé MA; Giraud P; Le Péchoux C; Cellier P; Denis F; Paumier A
    Cancer Radiother; 2012 Oct; 16(7):619-26. PubMed ID: 23089069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The superiority of hybrid-volumetric arc therapy (VMAT) technique over double arcs VMAT and 3D-conformal technique in the treatment of locally advanced non-small cell lung cancer--a planning study.
    Chan OS; Lee MC; Hung AW; Chang AT; Yeung RM; Lee AW
    Radiother Oncol; 2011 Nov; 101(2):298-302. PubMed ID: 21907438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of multiple isocentric volumetric modulated arc therapy technique for craniospinal axis radiotherapy planning.
    Lee YK; Brooks CJ; Bedford JL; Warrington AP; Saran FH
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):1006-12. PubMed ID: 21345612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
    Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F;
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volumetric modulated arc therapy for delivery of hypofractionated stereotactic lung radiotherapy: A dosimetric and treatment efficiency analysis.
    McGrath SD; Matuszak MM; Yan D; Kestin LL; Martinez AA; Grills IS
    Radiother Oncol; 2010 May; 95(2):153-7. PubMed ID: 20116115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Flattening Filter Free on Three-dimensional Conformal Radiation Therapy (3D-CRT), Intensity-Modulated Radiation Therapy (IMRT), and Volumetric Modulated Arc Therapy (VMAT) Plans for Metastatic Brain Tumors from Non-small Cell Lung Cancer.
    Shi LW; Lai YQ; Lin Q; Ha HM; Fu LR
    Health Phys; 2015 Jul; 109(1):1-9. PubMed ID: 26011493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
    Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
    Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiotherapy: volumetric modulated arc therapy versus 3D non-coplanar conformal radiotherapy for the treatment of early stage lung cancer.
    Herbert C; Kwa W; Nakano S; James K; Moiseenko V; Wu J; Schellenberg D; Liu M
    Technol Cancer Res Treat; 2013 Dec; 12(6):511-6. PubMed ID: 23617285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circumferential or sectored beam arrangements for stereotactic body radiation therapy (SBRT) of primary lung tumors: effect on target and normal-structure dose-volume metrics.
    Rosenberg MW; Kato CM; Carson KM; Matsunaga NM; Arao RF; Doss EJ; McCracken CL; Meng LZ; Chen Y; Laub WU; Fuss M; Tanyi JA
    Med Dosim; 2013; 38(4):407-12. PubMed ID: 23810414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
    Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
    Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
    Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tomotherapy as a neoadjuvant treatment for locally advanced esophageal cancer might increase bone marrow toxicity in comparison with intensity-modulated radiotherapy and volumetric-modulated arc therapy.
    Wang Y; Xiao Q; Zeng B; Ni Q; Liu X; Liu X; Tian L; Sheng C; Peng L; Wang H
    Med Dosim; 2020 Spring; 45(1):e6-e12. PubMed ID: 31176536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
    Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does VMAT for treatment of NSCLC patients increase the risk of pneumonitis compared to IMRT ? - a planning study.
    Bertelsen A; Hansen O; Brink C
    Acta Oncol; 2012 Jul; 51(6):752-8. PubMed ID: 22248064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy.
    Kannarunimit D; Descovich M; Garcia A; Chen J; Weinberg V; Mcguinness C; Pinnaduwage D; Murnane J; Gottschalk AR; Yom SS
    Technol Cancer Res Treat; 2015 Feb; 14(1):49-60. PubMed ID: 24325136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
    Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actual gains in dosimetry and treatment delivery efficiency from volumetric modulated arc radiotherapy for inoperable, locally advanced lung cancer over five-field forward-planned intensity-modulated radiotherapy.
    Shrimali RK; Arunsingh M; Reddy GD; Mandal S; Arun B; Prasath S; Sinha S; Mallick I; Achari R; Chatterjee S
    Indian J Cancer; 2017; 54(1):155-160. PubMed ID: 29199680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric evaluation of conventional radiotherapy, 3-D conformal radiotherapy and direct machine parameter optimisation intensity-modulated radiotherapy for breast cancer after conservative surgery.
    Zhang F; Zheng M
    J Med Imaging Radiat Oncol; 2011 Dec; 55(6):595-602. PubMed ID: 22141607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
    Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
    Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.